BSE Live
Jan 16, 16:01Prev. Close
22.25
Open Price
23.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Beryl Drugs (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.17 | 0.53 | 0.76 | 0.17 | 0.16 | |
| Diluted EPS (Rs.) | 0.17 | 0.53 | 0.76 | 0.17 | 0.16 | |
| Cash EPS (Rs.) | 1.18 | 1.15 | 1.35 | 0.74 | 0.76 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 12.75 | 12.60 | 12.09 | 11.32 | 11.15 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 12.75 | 12.60 | 12.09 | 11.32 | 11.15 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 26.08 | 28.65 | 28.93 | 18.30 | 14.90 | |
| PBDIT/Share (Rs.) | 1.86 | 1.84 | 2.14 | 1.11 | 1.10 | |
| PBIT/Share (Rs.) | 0.85 | 1.22 | 1.57 | 0.55 | 0.50 | |
| PBT/Share (Rs.) | 0.33 | 0.85 | 1.28 | 0.25 | 0.25 | |
| Net Profit/Share (Rs.) | 0.17 | 0.52 | 0.77 | 0.17 | 0.16 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 7.12 | 6.43 | 7.39 | 6.09 | 7.35 | |
| PBIT Margin (%) | 3.24 | 4.24 | 5.41 | 3.02 | 3.34 | |
| PBT Margin (%) | 1.27 | 2.95 | 4.42 | 1.34 | 1.68 | |
| Net Profit Margin (%) | 0.63 | 1.82 | 2.66 | 0.95 | 1.09 | |
| Return on Networth / Equity (%) | 1.29 | 4.15 | 6.37 | 1.54 | 1.46 | |
| Return on Capital Employed (%) | 1.25 | 4.06 | 6.24 | 1.52 | 1.44 | |
| Return on Assets (%) | 0.77 | 2.72 | 4.36 | 1.03 | 1.02 | |
| Total Debt/Equity (X) | 0.26 | 0.24 | 0.15 | 0.16 | 0.18 | |
| Asset Turnover Ratio (%) | 121.69 | 149.05 | 163.80 | 108.82 | 93.58 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.52 | 1.53 | 1.49 | 1.48 | 1.69 | |
| Quick Ratio (X) | 1.17 | 1.10 | 1.18 | 0.99 | 0.91 | |
| Inventory Turnover Ratio (X) | 8.84 | 10.38 | 17.51 | 7.05 | 4.12 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 19.81 | 20.12 | 14.86 | 9.33 | 10.55 | |
| EV/Net Operating Revenue (X) | 1.49 | 1.38 | 1.02 | 1.01 | 1.40 | |
| EV/EBITDA (X) | 20.92 | 21.42 | 13.72 | 16.55 | 19.01 | |
| MarketCap/Net Operating Revenue (X) | 1.42 | 1.29 | 0.97 | 0.93 | 1.27 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 2.91 | 2.92 | 2.32 | 1.50 | 1.70 | |
| Price/Net Operating Revenue | 1.42 | 1.29 | 0.97 | 0.93 | 1.27 | |
| Earnings Yield | 0.00 | 0.01 | 0.03 | 0.01 | 0.01 |
14.11.2025
Beryl Drugs Standalone September 2025 Net Sales at Rs 5.12 crore, down 8.8% Y-o-Y
22.08.2025
Beryl Drugs Standalone June 2025 Net Sales at Rs 4.79 crore, down 23.28% Y-o-Y
12.06.2025
Beryl Drugs Standalone March 2025 Net Sales at Rs 3.97 crore, up 33.54% Y-o-Y
14.02.2025
Beryl Drugs Standalone December 2024 Net Sales at Rs 5.31 crore, down 30.35% Y-o-Y
14.11.2025
Beryl Drugs Standalone September 2025 Net Sales at Rs 5.12 crore, down 8.8% Y-o-Y
22.08.2025
Beryl Drugs Standalone June 2025 Net Sales at Rs 4.79 crore, down 23.28% Y-o-Y
12.06.2025
Beryl Drugs Standalone March 2025 Net Sales at Rs 3.97 crore, up 33.54% Y-o-Y
14.02.2025
Beryl Drugs Standalone December 2024 Net Sales at Rs 5.31 crore, down 30.35% Y-o-Y